Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
Date:8/2/2012

NASHVILLE, Tenn., Aug. 2, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced second quarter 2012 financial results.

Net Revenues:  For the three months ended June 30, 2012, net revenues were $12.4 million, compared to $14.4 million in the prior year period.  

For the six months ended June 30, 2012, net revenue was $22.6 million compared with $25.1 million for the six months ended June 30, 2011. Prior year revenues were boosted by an increase in Acetadote volume due to shortages of competitive products.

Operating Expenses:  Total operating expenses for the three months ended June 30, 2012, were $10.4 million compared with $10.8 million for the prior year period.  This decrease was driven by lower selling and marketing expenses partially offset by an increase in research and development expenses. For the six months ended June 30, 2012, total operating expenses were $20.0 million, the same as the prior year period ended June 30, 2011.

Net Income:  Net income attributable to common shareholders for the three months ended June 30, 2012, was $1.7 million, or $0.09 per diluted share, compared to $2.2 million, or $0.11 per diluted share, for the prior year period.

For the six months ended June 30, 2012, net income attributable to common shareholders was $2.2 million, or $0.11 per diluted share, compared with $2.9 million, or $0.14 per diluted share, for the same period in 2011.

Cash Flow:  For the six months ended June 30, 2012, operating cash flows were $3.2 million compared to $4.9 million for the six months ended June 30, 2011.

Balance Sheet:  As of June 30, 2012, Cumberland had $70.5 million in cash and securities, with approximately $52.3 million in cash and equivalents and
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
2. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
3. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
4. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
5. Global Pharmaceuticals Market 2011-2015
6. Onyx Pharmaceuticals Reports Second Quarter 2012 Financial Results
7. MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock
8. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
9. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
10. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
11. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23 2014 Ampio Pharmaceuticals, ... its new headquarters, manufacturing and research facility: ... 80112 Direct: (720) 437-6500 ... efficient, pharmaceutical drug manufacturing facility will be fully operational ... the first batches of Ampion TM necessary to ...
(Date:7/23/2014)... July 23, 2014  ArmaGen, a privately held ... treat severe neurological disorders, announced today that it ... agreement with Shire plc to develop AGT-182, an ... of both the central nervous system (CNS) and ... as MPS II, Hunter syndrome is a rare, ...
(Date:7/22/2014)... - Investment to Foster Early Biotech Start-ups ... a fully-fledged oncology pharmaceutical company, announced on July 23 ... Remiges BioPharma Fund (hereinafter "Remiges Fund"), a newly formed ... long history of developing new therapeutic options to serve ... of TAS-102 is an example of our commitment to ...
Breaking Medicine Technology:Ampio Pharmaceuticals announces the opening of its new headquarters, manufacturing and research facility in Englewood Colorado 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 2ArmaGen Announces Strategic Licensing and Collaboration Agreement with Shire to Develop AGT-182 for Treatment of Hunter Syndrome 3Taiho Pharmaceutical Invests US$30 Million in Remiges BioPharma Fund, LP 2
(Date:7/23/2014)... 2014 The North American market was valued ... grow at a CAGR of 10.79%, to reach $1,801.1 million ... America. , The North American Bromine Market report defines and ... of revenue. , Browse through the TOC of the North ... in-depth analysis provided. This also provides a glimpse of the ...
(Date:7/23/2014)... MI (PRWEB) July 23, 2014 A ... that gets clients off to a great start and ... believe in, has launched a new Internet Addiction section ... people are surprised to learn that Internet addiction is ... or drug addiction, but that it’s trapping more and ...
(Date:7/23/2014)... Drilling fluid and Completion fluid Market Report defines and segments ... analysis and forecast of revenue. The drilling fluid and completion ... $1.3 billion in 2013 to $1.7 billion by 2018, at ... through the TOC of the Europe drilling fluid and completion ... analysis provided. This also provides a glimpse of the segmentation ...
(Date:7/23/2014)... RFcnn.com, a distinguished electrical equipment retailer, has ... . What’s more, the company has decided to provide big ... who place an order for the company’s brand new SMA ... , The high quality SMA JACK from RFcnn.com Provides ... superb quality electrical equipment to help make things much easier ...
(Date:7/23/2014)... 23, 2014) Statins, a class of drugs commonly ... risk of developing Barrett,s esophagus, according to a new ... the official journal of the American Gastroenterological Association. Obese ... statin use. , "Patients who received statins had a ... esophagus compared to non-users," said study author Hashem B. ...
Breaking Medicine News(10 mins):Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Drilling Fluid & Completion Fluid Market is Expected to Reach $1.7 Billion in 2018 - New Report by MicroMarket Monitor 6Health News:New Collection of SMA JACK Released by China Electrical Accessory Manufacturer RFcnn 2Health News:Statin use decreases the risk of Barrett's esophagus 2
... type of bark with right canine expression, researcher says , ... A new study suggests that 6-month-old babies know the answer. ... figure out that an aggressive bark goes with an angry-looking ... their feelings in a different way. , The babies managed ...
... OLYMPIA, Wash., July 24 Washington Drug Card is ... healthcare facilities the ability to private label the free drug ... own custom cards so that they can receive credit for ... drug card program. , , ...
... is surgery or percutaneous aspiration, injection and reaspiration (PAIR) ... causing permanent damage to the endocyst - the thin, ... fluid and generates new larval elements able to expand ... can result in biliary or bronchial fistulae, prompted by ...
... 24 /PRNewswire-Asia/ -- Neusoft Medical Systems Co.,Ltd. (Neusoft Medical), ... that its newly developed Computed,Tomography(CT) system, NeuViz 16 multi-slice ... is also marked as the first of its kind ... shipped to its U.S.-based customers,recently, Neusoft Medical has made ...
... accident patients may offer a medical heads-up, study says, ... blood-alcohol level of trauma patients could help medical personnel ... issues, a new study says. , People who ... in the dark about potentially serious health needs. But ...
... , , , , ... MedWorks ( www.medworksusa.org ) will provide free access for the ... 8 a.m. to 4 p.m. Saturday and Sunday, July 25 and 26, ... first mass health clinic sponsored by MedWorks and will provide 1100 medical, ...
Cached Medicine News:Health News:Babies Can Comprehend 'Canine' Language 2Health News:Is RTA a new potential option for the treatment of hydatid cysts? 2Health News:Is RTA a new potential option for the treatment of hydatid cysts? 3Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 2Health News:Neusoft Medical's Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market 3Health News:Alcohol and Trauma: Blood Test Gets to the Truth 2Health News:U.S. Senator Sherrod Brown to Lend Support at MedWorks' Free Medical Clinic This Weekend 2
... Electrohydraulic Lithotriptor combines efficient stone fragmentation, low ... a large, clear LED display, automatic probe ... according to probe size. In addition, the ... end-of-life, and can also regulate and control ...
Electrohydraulic Lithotripsy Probe for AEH-2 & AEH-3...
Short double-horn bridge for insertion of instruments...
Only SurLok combines precise control, enhanced basket and grasper strength, and the added security of a unique wire-locking mechanism. You can feel the difference. The SurLok flat-wire and grasper ha...
Medicine Products: